Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen and India’s Jubilant In Drug Discovery Partnership

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Jubilant Biosys, a subsidiary of Indian contract research and manufacturing services provider Jubilant Organosys, has entered into a drug discovery partnership with Amgen to develop a portfolio of new drugs across various therapeutic areas
Advertisement

Related Content

India’s Jubilant Shakes Hands With Endo Pharma For Drug Discovery,
India’s Jubilant Shakes Hands With Endo Pharma For Drug Discovery,
India’s Jubilant Shakes Hands With Endo Pharma For Drug Discovery, Strikes Its Sixth Partnership In 18 Months
India’s Jubilant Shakes Hands With Endo Pharma For Drug Discovery, Strikes Its Sixth Partnership In 18 Months
Indian Companies Look To Emphasize Drug Technology Advantages Rather Than Cost Savings With MNCs
Indian Companies Look To Emphasize Drug Technology Advantages Rather Than Cost Savings With MNCs
Amgen Expands Hep C Agreement With Three Rivers To China
Indian CROs Move Up R&D Value Chain From Outsourcing Services To Partnering With MNCs
PharmAsia News Spotlight On India: Smaller R&D Units To Dominate India - Study
PharmAsia News Spotlight On India: Smaller R&D Units To Dominate India - Study
Advertisement
UsernamePublicRestriction

Register

SC069115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel